Home > Insider Trading > Filing (0000904454-13-001016)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1369786	Sagent Pharmaceuticals Inc.	SGNT	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1398936	Vivo Ventures V Affiliates Fund, L.p.	575 High Street, Suite 201 Palo Alto CA 94301	No	No	Yes	No
1398937	Vivo Ventures Fund V, L.p.	575 High Street, Suite 201 Palo Alto CA 94301	No	No	Yes	No
1399028	Vivo Ventures V, Llc	575 High Street, Suite 201 Palo Alto CA 94301	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2013-09-16	532,765	$21.25	3,576,966	No	4	S	Indirect	See footnote
Common Stock	Disposition	2013-09-16	6,252	$21.25	41,980	No	4	S	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote

Footnotes

In connection with the Issuer's registered offering (the "Offering"), Vivo Ventures Fund V, L.P. ("Fund V") sold 532,765 shares of the Issuer's common stock ("Common Stock") pursuant to an underwriting agreement, dated September 10, 2013 by and among the Issuer, the underwriters and the selling stockholders party thereto (the "Underwriting Agreement")
In connection with the Offering, Vivo Ventures V Affiliates Fund, L.P. ("V Affiliates Fund") sold 6,252 shares of Common Stock pursuant to the Underwriting Agreement.
Immediately following the consummation of the Offering, Fund V owns an aggregate of 3,576,966 shares of Common Stock. Vivo Ventures V, LLC, the sole general partner of Fund V, may be deemed to be the beneficial owner of the shares held by Fund V. Vivo Ventures V, LLC hereby disclaims any beneficial ownership of any shares directly held by Fund V, except to the extent of its pecuniary interest therein.
Immediately following the consummation of the Offering, V Affiliates Fund owns an aggregate of 41,980 shares of Common Stock. Vivo Ventures V, LLC, the sole general partner of V Affiliates Fund, may be deemed to be the beneficial owner of the shares held by V Affiliates Fund. Vivo Ventures V, LLC hereby disclaims any beneficial ownership of any shares directly held by V Affiliates Fund, except to the extent of its pecuniary interest therein.